Tobacco Cessation Program for Tobacco Use

Overseen By Erika Barahona, M. Ed

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Florida

Disqualifiers: Incarceration, Detained, Language barriers, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 4

204 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training. Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

Who Is on the Research Team?

Jennifer LeLaurin, PhD

Principal Investigator

University of Florida

Are You a Good Fit for This Trial?

This trial is for cancer survivors, including those currently in treatment, and their caregivers who use tobacco. Participants must be capable of completing study tasks and receiving care from specific UF Health clinics. They need to have used tobacco recently and consent to the study's processes.

Inclusion Criteria

I have signed the consent form and agree to follow the study rules.

I am a caregiver or family member of someone who has survived cancer.

I am a caregiver or friend of a cancer survivor at UF Health.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Nicotine Cessation Program

Participants, including cancer survivors and caregivers, engage in a tailored nicotine cessation program

8 weeks

4 sessions

Healthcare Provider Training

Healthcare providers receive training on the AAC model and C-LEAR approach for tobacco cessation in cancer care

1-2 weeks

Follow-up

Participants are monitored for program effectiveness and satisfaction, including tobacco cessation success

3-5 months

What Are the Treatments Tested in This Trial?

Interventions

• Nicotine cessation program

Trial Overview The trial tests a tailored nicotine cessation program for cancer survivors and their caregivers. It includes two strategies: a personalized quitting program and healthcare provider training using the AAC model (Ask, Advise, Connect) plus C-LEAR communication skills.

How Is the Trial Designed?

Group I: Nicotine Cessation Program Experimental Treatment 1 Intervention

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials

1,428

Recruited

987,000+